Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence HolderTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
TABLET, EXTENDED RELEASE
ORAL
Medical Information
A10BB09
gliclazide
Manufacturer Information
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
BALKANPHARMA-DUPNITSA AD